Skip to main content
OpenTrials
Completed

NCT Number: NCT03329040

Is Primiparity a Risk Factor for Neonatal Hyperbilirubinemia?

Neonatal hyperbilirubinemia elongates hospital stay and may require treatment. The investigators noticed that bilirubin levels were higher among infants of primipara mothers than among multipara mothers. As this data is dichotomic and easy to produce, and may influence the maintenance, the investigators decided to find out if primiparity is a risk factor for neonatal hyperbilirubinemia. The investigators intend to collect data from patient files during one year, and compare the bilirubin levels and length of stay between newborns to primipara mothers and multipara mothers.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hyperbilirubinemia, Neonatal Congenital, Hereditary, and Neonatal Diseases and Abnormalities Hyperbilirubinemia Infant, Newborn, Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

Up to 14 day

Sex eligibility

All sexes

Study type

Observational

Primary location

Hillel Yaffe medical center

Hadera, 38100, Israel

About this study

Neonatal hyperbilirubinemia elongates hospital stay and may require treatment. The investigators noticed that bilirubin levels were higher among infants of primipara mothers than among multipara mothers. As this data is dichotomic and easy to produce, and may influence the maintenance, the investigators decided to find out if primiparity is a risk factor for neonatal hyperbilirubinemia. The investigators intend to collect data from patient files during one year, and compare the bilirubin levels and length of stay between newborns to primipara mothers and multipara mothers.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All infants that were born during one year in a single medical center and were transferred to well baby nursery, and were discharged from the well baby nursery.

Exclusion criteria

  • Infants who were transferred to neonatal intensive care unit due to any reason.
  • Infants whose mother could not take care of them (due to admission to intensive care unit, or due to adoption)

Treatment and study plan

No intervention.

Other

No intervention.

Primary outcomes

  1. Length of stay of the infant

    Time frame: 2 weeks

    Length of stay of the infant

Secondary outcomes

  1. Highest bilirubin level

    Time frame: 2 weeks

    Highest bilirubin level

  2. Age at highest bilirubin level

    Time frame: 2 weeks

    Age at highest bilirubin level

Sponsors and collaborators

Lead sponsor

Hillel Yaffe Medical Center

Other Gov

Registry information

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Nov 1, 2017
Registry last updated
Sep 21, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.